A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Osteosarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Zhaoming Ye, M.D.) · yezhaoming@zju.edu.cn · 0086 13606501549

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Desmoplastic Small Round Cell Tumor · Osteosarcoma · Recurrent Desmoplastic Small Round Cell Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Los Angeles, United States

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Sarcoma · Osteoid Sarcoma · Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

Metastatic Leiomyosarcoma · Unresectable Leiomyosarcoma · Bone Sarcoma

Abroad (travel likely)RecruitingPHASE2

Chicago, United States

Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma (STS) · Osteosarcoma

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China